• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脑脊液屏障功能障碍与结核性脑膜炎患者治疗效果之间的关联。

The association between blood-cerebrospinal fluid barrier dysfunction and the therapeutic effect in tuberculous meningitis patients.

作者信息

Tang Jiangtao, An Yunfei, Liao Yun, Li Yi, Li Lixin, Wang Lanlan

机构信息

Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, PR China.

出版信息

Eur Neurol. 2014;71(5-6):331-6. doi: 10.1159/000358219. Epub 2014 Apr 24.

DOI:10.1159/000358219
PMID:24776964
Abstract

OBJECTIVE

To explore the correlation of blood-cerebrospinal fluid (CSF) barrier (BCB) dysfunction with the therapeutic effect of antitubercular agents and their resistance, hoping to provide theoretical evidence for improvement of the therapeutic effect.

METHODS

Albumin in CSF and serum was assayed by IMMAGE. The CSF/serum albumin ratio (QALB) was used to evaluate the permeability of the BCB. Real-time fluorescence quantitative PCR was used to detect the amount of Mycobacterium tuberculosis DNA, and an MTBDRplus reagent kit was used to determine the type of drug resistance of the M. tuberculosis.

RESULTS

The correlation analysis showed that significant correlation existed between the grade of severity of tuberculous meningitis and the QALB, and the grade of severity and the total leukocyte count in the CSF, for which the correlation coefficients were 0.366 (p < 0.05) and 0.365 (p < 0.05), respectively. The QALB in the group of patients who recovered was significantly higher than that in those patients who experienced disease progression (p = 0.019).

CONCLUSIONS

Our study showed that the permeability of the BCB correlated with the cure rate in tuberculous meningitis. Specifically, in the treatment of tuberculous meningitis, it is of key importance to utilize the benefit of the permeability of the BCB to achieve a better outcome.

摘要

目的

探讨血脑脊液屏障(BCB)功能障碍与抗结核药物治疗效果及其耐药性之间的相关性,以期为提高治疗效果提供理论依据。

方法

采用IMMAGE法检测脑脊液和血清中的白蛋白。脑脊液/血清白蛋白比值(QALB)用于评估血脑脊液屏障的通透性。采用实时荧光定量PCR检测结核分枝杆菌DNA含量,并用MTBDRplus试剂试剂盒确定结核分枝杆菌的耐药类型。

结果

相关性分析显示,结核性脑膜炎的严重程度分级与QALB以及严重程度分级与脑脊液中的白细胞总数之间存在显著相关性,相关系数分别为0.366(p<0.05)和0.365(p<0.05)。康复患者组的QALB显著高于病情进展患者组(p = 0.019)。

结论

我们的研究表明,血脑脊液屏障的通透性与结核性脑膜炎的治愈率相关。具体而言,在结核性脑膜炎的治疗中,利用血脑脊液屏障的通透性优势以获得更好的治疗效果至关重要。

相似文献

1
The association between blood-cerebrospinal fluid barrier dysfunction and the therapeutic effect in tuberculous meningitis patients.血脑脊液屏障功能障碍与结核性脑膜炎患者治疗效果之间的关联。
Eur Neurol. 2014;71(5-6):331-6. doi: 10.1159/000358219. Epub 2014 Apr 24.
2
Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.血管内皮生长因子与结核性脑膜炎中的血脑屏障破坏
Pediatr Infect Dis J. 2004 Jul;23(7):608-13. doi: 10.1097/01.inf.0000131634.57368.45.
3
[The course and outcome of tuberculous meningitis in cases of detection of Mycobacterium tuberculosis in the cerebrospinal fluid].[脑脊液中检测到结核分枝杆菌的结核性脑膜炎病例的病程及转归]
Probl Tuberk. 1990(7):41-3.
4
Clinical features, Outcomes and Molecular Profiles of Drug Resistance in Tuberculous Meningitis in non-HIV Patients.非HIV感染患者结核性脑膜炎的临床特征、结局及耐药分子特征
Sci Rep. 2016 Jan 7;6:19072. doi: 10.1038/srep19072.
5
Molecular profile of drug resistance in tuberculous meningitis from southwest china.中国西南地区结核性脑膜炎耐药的分子特征。
Clin Infect Dis. 2011 Dec;53(11):1067-73. doi: 10.1093/cid/cir663. Epub 2011 Oct 21.
6
A review of tuberculous meningitis at Auckland City Hospital, New Zealand.新西兰奥克兰市医院结核性脑膜炎综述。
J Clin Neurosci. 2010 Aug;17(8):1018-22. doi: 10.1016/j.jocn.2010.01.007. Epub 2010 Jun 3.
7
Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.结核性脑膜炎患者的脑脊液基质金属蛋白酶9水平、血脑屏障通透性及治疗结果
PLoS One. 2017 Jul 12;12(7):e0181262. doi: 10.1371/journal.pone.0181262. eCollection 2017.
8
Isoniazid resistance, mycobacterial genotype and outcome in Vietnamese adults with tuberculous meningitis.越南成人结核性脑膜炎患者的异烟肼耐药性、分枝杆菌基因型及转归
Int J Tuberc Lung Dis. 2002 Oct;6(10):865-71.
9
Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.越南成年结核性脑膜炎患者的病理生理学与预后
J Infect Dis. 2003 Oct 15;188(8):1105-15. doi: 10.1086/378642. Epub 2003 Oct 2.
10
Tuberculous meningitis in HIV-infected and non-infected patients: comparison of cerebrospinal fluid findings.HIV感染和未感染患者的结核性脑膜炎:脑脊液检查结果比较
Int J Tuberc Lung Dis. 2009 Feb;13(2):269-71.

引用本文的文献

1
Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.结核性脑膜炎治疗中脑脊液中目标利福平浓度的达到情况。
Int J Infect Dis. 2019 Jul;84:15-21. doi: 10.1016/j.ijid.2019.04.026. Epub 2019 Apr 30.
2
Comparison of Clinical Features and Prognostic Factors of Cryptococcal Meningitis Caused by Cryptococcus neoformans in Patients With and Without Pulmonary Nodules.新型隐球菌性脑膜炎患者肺部结节与无肺部结节的临床特征和预后因素比较。
Mycopathologia. 2019 Feb;184(1):73-80. doi: 10.1007/s11046-018-0263-8. Epub 2018 May 8.
3
Strategies to target drugs to gliomas and CNS metastases of solid tumors.
将药物靶向胶质瘤和实体瘤中枢神经系统转移灶的策略。
J Neurol. 2016 Mar;263(3):428-40. doi: 10.1007/s00415-015-7919-9. Epub 2015 Oct 17.